DJIA 18,086.32 56.11 0.31%
NASDAQ 4,810.41 36.93 0.77%
S&P 500 2,091.33 9.45 0.45%
market minute promo

Mylan Inc. (NASDAQ: MYL)

57.47 0.50 (0.88%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

MYL $57.47 0.88%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $56.99
Previous Close $56.97
Daily Range $56.99 - $57.68
52-Week Range $41.97 - $59.60
Market Cap $21.5B
P/E Ratio 24.66
Dividend (Yield) $0.00 (0.0%)
Volume 446,473
Average Daily Volume 3,343,833
Current FY EPS $3.56

Sector

Healthcare

Industry

Drugs

Mylan Inc. (MYL) Description

The Company develops, licenses, manufactures, markets and distributes generic, brand and branded generic pharmaceutical products and active pharmaceutical ingredients. Website: http://www.mylan.com/

News & Commentary

3 Cheap Dividend Stocks That Could Be Top Stocks in 2015

Owens & Minor, Kindred Healthcare, and Teva Pharmaceuticals are three dividend-paying companies that could reward investors next year.

Actavis' Antibiotic a Step Closer to EU Nod, CHMP Positive - Analyst Blog

Actavis' Antibiotic a Step Closer to EU Nod, CHMP Positive - Analyst Blog

Hold On To Teva!

Health Care Sector Update for 12/22/2014: CFRX, KERX, MYL

Pfizer's Duchenne Muscular Dystrophy Drug in Phase II - Analyst Blog

Pfizer's Duchenne Muscular Dystrophy Drug in Phase II - Analyst Blog

Top 4 Small-Cap Stocks In The Drugs-Generic Industry With The Lowest PEG Ratio

Actavis to Appeal Ruling Regarding Namenda IR Sales - Analyst Blog

Teva's (TEVA) 2015 Guidance Hit By Generics - Analyst Blog

Teva's (TEVA) 2015 Guidance Hit By Generics - Analyst Blog

Actavis Likely to Continue Selling Namenda IR Tablets - Analyst Blog

Mylan Among First to Launch Generic Celebrex - Analyst Blog

Supernus Faces another Patent Challenge for Oxtellar XR - Analyst Blog

See More MYL News...

MYL's Top Competitors

MYL $57.47 (0.88%)
Current stock: MYL
JNJ $105.25 (0.63%)
Current stock: JNJ
NVS $94.25 (0.36%)
Current stock: NVS
RHHBY $34.25 (-0.10%)
Current stock: RHHBY